top of page

Antheia Receives Phase II SBIR Awards to Develop Safer Manufacturing Processes for Painkillers

This NSF Phase II award "A complete bioprocess for medicinal plant opioids" has built upon the early-stage R&D completed under the Phase I award (1621560). The initial grant focused heavily on strain development to engineer an extensive heterologous pathway to produce thebaine and downstream opioids from a simple carbon source in yeast and transferring this technology from an academic lab to an industrial setting at Antheia.

Read more about the award at the National Science Foundation

bottom of page